159 related articles for article (PubMed ID: 38803421)
1. Sequencing-guided design of genetically encoded small RNAs targeting CAG repeats for selective inhibition of mutant
Parasrampuria MA; White AA; Chilamkurthy R; Pater AA; El-Azzouzi F; Ovington KN; Jensik PJ; Gagnon KT
Mol Ther Nucleic Acids; 2024 Jun; 35(2):102206. PubMed ID: 38803421
[TBL] [Abstract][Full Text] [Related]
2. Allele-selective inhibition of mutant huntingtin expression with antisense oligonucleotides targeting the expanded CAG repeat.
Gagnon KT; Pendergraff HM; Deleavey GF; Swayze EE; Potier P; Randolph J; Roesch EB; Chattopadhyaya J; Damha MJ; Bennett CF; Montaillier C; Lemaitre M; Corey DR
Biochemistry; 2010 Nov; 49(47):10166-78. PubMed ID: 21028906
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of allele-selective inhibition of huntingtin expression by duplex RNAs that target CAG repeats: function through the RNAi pathway.
Hu J; Liu J; Yu D; Chu Y; Corey DR
Nucleic Acids Res; 2012 Dec; 40(22):11270-80. PubMed ID: 23042244
[TBL] [Abstract][Full Text] [Related]
4. A CAG repeat-targeting artificial miRNA lowers the mutant huntingtin level in the YAC128 model of Huntington's disease.
Kotowska-Zimmer A; Przybyl L; Pewinska M; Suszynska-Zajczyk J; Wronka D; Figiel M; Olejniczak M
Mol Ther Nucleic Acids; 2022 Jun; 28():702-715. PubMed ID: 35664700
[TBL] [Abstract][Full Text] [Related]
5. Increased Steady-State Mutant Huntingtin mRNA in Huntington's Disease Brain.
Liu W; Chaurette J; Pfister EL; Kennington LA; Chase KO; Bullock J; Vonsattel JP; Faull RL; Macdonald D; DiFiglia M; Zamore PD; Aronin N
J Huntingtons Dis; 2013; 2(4):491-500. PubMed ID: 25062733
[TBL] [Abstract][Full Text] [Related]
6. A pathogenic mechanism in Huntington's disease involves small CAG-repeated RNAs with neurotoxic activity.
Bañez-Coronel M; Porta S; Kagerbauer B; Mateu-Huertas E; Pantano L; Ferrer I; Guzmán M; Estivill X; Martí E
PLoS Genet; 2012; 8(2):e1002481. PubMed ID: 22383888
[TBL] [Abstract][Full Text] [Related]
7. Self-duplexing CUG repeats selectively inhibit mutant huntingtin expression.
Fiszer A; Olejniczak M; Galka-Marciniak P; Mykowska A; Krzyzosiak WJ
Nucleic Acids Res; 2013 Dec; 41(22):10426-37. PubMed ID: 24038471
[TBL] [Abstract][Full Text] [Related]
8. Allele-specific quantitation of ATXN3 and HTT transcripts in polyQ disease models.
Joachimiak P; Ciesiołka A; Kozłowska E; Świtoński PM; Figura G; Ciołak A; Adamek G; Surdyka M; Kalinowska-Pośka Ż; Figiel M; Caron NS; Hayden MR; Fiszer A
BMC Biol; 2023 Feb; 21(1):17. PubMed ID: 36726088
[TBL] [Abstract][Full Text] [Related]
9. Targeting CAG repeat RNAs reduces Huntington's disease phenotype independently of huntingtin levels.
Rué L; Bañez-Coronel M; Creus-Muncunill J; Giralt A; Alcalá-Vida R; Mentxaka G; Kagerbauer B; Zomeño-Abellán MT; Aranda Z; Venturi V; Pérez-Navarro E; Estivill X; Martí E
J Clin Invest; 2016 Nov; 126(11):4319-4330. PubMed ID: 27721240
[TBL] [Abstract][Full Text] [Related]
10. Phosphorodiamidate morpholino oligomers suppress mutant huntingtin expression and attenuate neurotoxicity.
Sun X; Marque LO; Cordner Z; Pruitt JL; Bhat M; Li PP; Kannan G; Ladenheim EE; Moran TH; Margolis RL; Rudnicki DD
Hum Mol Genet; 2014 Dec; 23(23):6302-17. PubMed ID: 25035419
[TBL] [Abstract][Full Text] [Related]
11. Novel allele-specific quantification methods reveal no effects of adult onset CAG repeats on HTT mRNA and protein levels.
Shin A; Shin B; Shin JW; Kim KH; Atwal RS; Hope JM; Gillis T; Leszyk JD; Shaffer SA; Lee R; Kwak S; MacDonald ME; Gusella JF; Seong IS; Lee JM
Hum Mol Genet; 2017 Apr; 26(7):1258-1267. PubMed ID: 28165127
[TBL] [Abstract][Full Text] [Related]
12. Allele-selective inhibition of mutant atrophin-1 expression by duplex and single-stranded RNAs.
Hu J; Liu J; Narayanannair KJ; Lackey JG; Kuchimanchi S; Rajeev KG; Manoharan M; Swayze EE; Lima WF; Prakash TP; Xiang Q; Martinez C; Corey DR
Biochemistry; 2014 Jul; 53(28):4510-8. PubMed ID: 24981774
[TBL] [Abstract][Full Text] [Related]
13. Investigation of the Influence of TBP CAG/CAA Repeats in Conjunction with HTT CAG Repeats on Huntington's Disease Age at Onset in a Brazilian Sample.
da Silva IDS; Apolinário TA; de Andrade Agostinho L; Paiva CLA
J Mol Neurosci; 2022 May; 72(5):1116-1124. PubMed ID: 35275350
[TBL] [Abstract][Full Text] [Related]
14. Cas9-mediated replacement of expanded CAG repeats in a pig model of Huntington's disease.
Yan S; Zheng X; Lin Y; Li C; Liu Z; Li J; Tu Z; Zhao Y; Huang C; Chen Y; Li J; Song X; Han B; Wang W; Liang W; Lai L; Li XJ; Li S
Nat Biomed Eng; 2023 May; 7(5):629-646. PubMed ID: 36797418
[TBL] [Abstract][Full Text] [Related]
15. Exploring the effect of sequence length and composition on allele-selective inhibition of human huntingtin expression by single-stranded silencing RNAs.
Hu J; Liu J; Yu D; Aiba Y; Lee S; Pendergraff H; Boubaker J; Artates JW; Lagier-Tourenne C; Lima WF; Swayze EE; Prakash TP; Corey DR
Nucleic Acid Ther; 2014 Jun; 24(3):199-209. PubMed ID: 24694346
[TBL] [Abstract][Full Text] [Related]
16. The MID1 Protein: A Promising Therapeutic Target in Huntington's Disease.
Heinz A; Schilling J; van Roon-Mom W; Krauß S
Front Genet; 2021; 12():761714. PubMed ID: 34659371
[TBL] [Abstract][Full Text] [Related]
17. Artificial miRNAs targeting CAG repeat expansion in ORFs cause rapid deadenylation and translation inhibition of mutant transcripts.
Ciesiolka A; Stroynowska-Czerwinska A; Joachimiak P; Ciolak A; Kozlowska E; Michalak M; Dabrowska M; Olejniczak M; Raczynska KD; Zielinska D; Wozna-Wysocka M; Krzyzosiak WJ; Fiszer A
Cell Mol Life Sci; 2021 Feb; 78(4):1577-1596. PubMed ID: 32696070
[TBL] [Abstract][Full Text] [Related]
18. Precise Excision of the CAG Tract from the Huntingtin Gene by Cas9 Nickases.
Dabrowska M; Juzwa W; Krzyzosiak WJ; Olejniczak M
Front Neurosci; 2018; 12():75. PubMed ID: 29535594
[TBL] [Abstract][Full Text] [Related]
19. Efficient and Precise Processing of the Optimized Primary Artificial MicroRNA in a Huntingtin-Lowering Adeno-Associated Viral Gene Therapy
Wang W; Zhou P; Wang X; Chen F; Christensen E; Thompson J; Ren X; Kells A; Stanek L; Carter T; Hou J; Sah DWY
Hum Gene Ther; 2022 Jan; 33(1-2):37-60. PubMed ID: 34806402
[TBL] [Abstract][Full Text] [Related]
20. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.
Hu J; Liu J; Corey DR
Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
